{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:40:55Z","timestamp":1794559255330,"version":"4.9.1"},"reference-count":18,"publisher":"Wiley","issue":"S36","license":[{"start":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T00:00:00Z","timestamp":1276128000000},"content-version":"vor","delay-in-days":1409,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["beva.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Equine Veterinary Journal"],"published-print":{"date-parts":[[2006,8]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Reasons for performing study:<\/jats:italic>\n                    Oral chondroprotective supplements are commercially popular for veteran (and other athletic or arthritic) horses prone to joint degeneration, yet lack conclusive scientific support.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Objectives:<\/jats:italic>\n                    To quantify the effects of an oral joint supplement (combination glucosamine hydrochloride (GHCL), chondroitin sulphate (CS) and N\u2010acetyl\u2010D\u2010glucosamine)\n                    <jats:italic>in vivo<\/jats:italic>\n                    on stride parameters of veteran horses.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Methods:<\/jats:italic>\n                    Twenty veteran horses were randomly assigned to a treatment (n=15) or placebo group (n = 5). Pre\u2010treatment gait characteristics were recorded at trot using digital video footage (50 Hz). The range of joint motion, stride length, and swing and stance duration were assessed using 2\u2010dimensional motion analysis. Treatment (or placebo) was administered daily for 12 weeks at the manufacturer's recommended dosage. Gait was reassessed every 4 weeks using the pre\u2010treatment protocol. Double blind procedure was implemented throughout. Relationships between variables were analysed using General Linear Model.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results:<\/jats:italic>\n                    Differences occurred in the treated horses by week 8. Range of joint motion increased significantly in the elbow (P&lt;0.05), stifle and hind fetlock (P&lt;0.01). Stride length increased significantly (P&lt;0.05) with treatment. Swing duration was significantly increased at week 12 (P&lt;0.05), whilst stance duration remained constant.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion:<\/jats:italic>\n                    The oral chondroprotective offered symptomatic relief to veteran horses, evidenced by improved stride characteristics.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Potential relevance:<\/jats:italic>\n                    Oral GHCL and CS supplementation may improve welfare by alleviating symptoms of degenerative joint disease.\n                  <\/jats:p>","DOI":"10.1111\/j.2042-3306.2006.tb05615.x","type":"journal-article","created":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T23:41:02Z","timestamp":1276558862000},"page":"622-625","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Double blind investigation of the effects of oral supplementation of combined glucosamine hydrochloride (GHCL) and chondroitin sulphate (CS) on stride characteristics of veteran horses"],"prefix":"10.1111","volume":"38","author":[{"given":"R. K.","family":"FORSYTH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. V.","family":"BRIGDEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"NORTHROP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,10]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000147436"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2460\/ajvr.1999.60.03.341","article-title":"Influence of site and age on biochemical characteristics of the collagen network of equine articular cartilage","volume":"60","author":"Brama P. A. J.","year":"1999","journal-title":"Am. J. vet. Res."},{"key":"e_1_2_1_4_1","first-page":"275","article-title":"The biochemistry of degenerative joint disease and its treatment","volume":"13","author":"Clark D. M.","year":"1991","journal-title":"Comp. cont. Educ. pract. Vet."},{"key":"e_1_2_1_5_1","first-page":"317","article-title":"Double blind study of the effects of an oral supplement intended to support joint health in horses with tarsal degenerative joint disease","volume":"48","author":"Clayton H. M.","year":"2002","journal-title":"Proc. Am. Ass. equine Practnrs."},{"key":"e_1_2_1_6_1","first-page":"227","article-title":"Effects of glucosamine hydrochloride and chondroitin sulphate, alone and in combination, on normal and interleukin\u20101 conditioned equine articular cartilage explant metabolism","volume":"32","author":"Dechant J. E.","year":"2005","journal-title":"Equine vet. J."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0737-0806(98)80079-8"},{"key":"e_1_2_1_8_1","first-page":"16","article-title":"Oral treatment with a glucosamine\u2010chondroitin sulphate compound for degenerative joint disease in horses: 25 Cases","volume":"19","author":"Hanson R. R.","year":"1997","journal-title":"Equine Pract."},{"key":"e_1_2_1_9_1","first-page":"337","volume-title":"How to: Feed the older horse","author":"Jarvis N.","year":"2005"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1063-4584(03)00028-1"},{"issue":"6","key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.2042-3306.1988.tb04657.x","article-title":"Instant centres of rotation of equine limb joints and their relationship to standard skin marker locations","author":"Leach D. H.","year":"1988","journal-title":"Equine vet. J."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006408522233"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1063-4584(03)00026-8"},{"issue":"6","key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.2042-3306.1988.tb04641.x","article-title":"Review of pathogenesis and treatment of degenerative joint disease","author":"McIlwraith C. W.","year":"1988","journal-title":"Equine vet. J."},{"issue":"34","key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.2042-3306.2002.tb05423.x","article-title":"Inhibition of articular cartilage degradation by glucosamine HCL and chondroitin sulphate","author":"Orth M. W.","year":"2002","journal-title":"Equine vet. J."},{"key":"e_1_2_1_16_1","first-page":"87","volume-title":"Joint Disease in the Horse","author":"Pool R.","year":"1996"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0737-0806(06)81478-4"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-6226(99)00126-8"},{"key":"e_1_2_1_19_1","first-page":"295","article-title":"Efficacy of intramuscular chondroitin sulphate and compounded acetyl\u2010d\u2010glucosamine in a positive controlled study of equine carpitis","volume":"23","author":"White G. W.","year":"2003","journal-title":"Veterinary Review"}],"container-title":["Equine Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-3306.2006.tb05615.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/beva.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.2042-3306.2006.tb05615.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:06:42Z","timestamp":1762074402000},"score":1,"resource":{"primary":{"URL":"https:\/\/beva.onlinelibrary.wiley.com\/doi\/10.1111\/j.2042-3306.2006.tb05615.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":18,"journal-issue":{"issue":"S36","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["10.1111\/j.2042-3306.2006.tb05615.x"],"URL":"https:\/\/doi.org\/10.1111\/j.2042-3306.2006.tb05615.x","archive":["Portico"],"relation":{},"ISSN":["0425-1644","2042-3306"],"issn-type":[{"value":"0425-1644","type":"print"},{"value":"2042-3306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"2010-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}